SCHEMBL6830237

SCHEMBL6830237

CCN(CC)c1ccc(NS(=O)(=O)c2cc(C(=O)Nc3ccc(Br)cc3C(=O)O)cs2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPA1 P27694 2/20 0.47
GFER P55789 1/20 0.47
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
AKR1C2 P52895 3/20 0.43
AKR1C1 Q04828 3/20 0.43
MAPT P10636 5/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TSHR P16473 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
PTGES O14684 1/20 0.42
ALOX5 P09917 1/20 0.42
AKR1C4 P17516 1/20 0.42
AKR1C3 P42330 1/20 0.42
TDP1 Q9NUW8 2/20 0.40
POLB P06746 1/20 0.40
ABL1 P00519 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6355569 0.85 METAP2 (0.52) RPA1GFERMEN1KMT2AAKR1C2
SCHEMBL6835804 0.85 RPA1 (0.46) RPA1GFERMEN1KMT2AAKR1C2
SCHEMBL6353969 0.85 PTGES (0.61) RPA1GFERMEN1KMT2AAKR1C2
SCHEMBL6353520 0.84 RPA1 (0.68) RPA1GFERMEN1KMT2AAKR1C2
SCHEMBL6351450 0.83 MEN1 (0.67) RPA1GFERMEN1KMT2AAKR1C2
SCHEMBL6359829 0.80 KCNK2 (0.57) MEN1KMT2AAKR1C2AKR1C1MAPT
SCHEMBL6830007 0.79 MEN1 (0.44) MEN1KMT2AAKR1C2AKR1C1MAPT
SCHEMBL6830408 0.79 SMN1; SMN2 (0.48) RPA1GFERMEN1KMT2AAKR1C2
SCHEMBL6834402 0.76 AKR1C2 (0.47) MEN1KMT2AAKR1C2AKR1C1MAPT
SCHEMBL6819031 0.75 METAP2 (0.46) MEN1KMT2AAKR1C2AKR1C1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 RPA1 3767/4885GFER 900/4885MEN1 4132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.